HLA-E and neoplasm: When integrated with X-ray, mice treated with PSeR/DOX observably increased the tumor infiltration of NK1.1( +) NK cells, abated the expression level of HLA-E, and promoted the tumor inhibition rate, which was linked to the incorporation of radiotherapy, selenic acid-mediated immunotherapy, and chemotherapy (Fig. 5e, f).